Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients]

[On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients] Abstract Text:

     ,i i dement'evaI I Dement'eva,v g gladyshevaV G Gladysheva,m a charnaiaM A Charnaia,iu a morozovIu A Morozov,

    Recombinant activated factor VII was used in a dose of 30 to 140 mcgr/kg in 35 cardiosurgical patients during intra- and postoperative periods complicated by massive uncontrolled (5 to 25 ml/min) bleeding of non-surgical origin. Basing on the analysis of changes in the hemostasis system parameters, the mechanism of action of the preparation may be presented as follows: recombinant fVIIa forms a complex with TF at the site of lesion; the formation of TF-fVIIa complex leads to the appearance of small amount of synthesized thrombin on the membrane of TF-containing cells, which, in turn, activates thrombocytes at the site of lesion; thrombocytes excrete phosphatidylserine, which serves as a matrix for further thrombin formation. FXIII is expressed from a granules ofthrombocytes and gets activated. FXIII binds with a specific receptor on platelets' membrane. It remains active as enzyme and participates in the formation of a firm fibrin plug at the site of lesion. Besides, substances with pro- and antifibrinolytic activity, antiheparin factor 4 and fibronectin are released from alpha granules. Factors IXa, VIIIa, and Va effectively "attach" to the surface of activated thrombocytes, and the forming of IXa-VIIIa complex leads to further activation of factor X, which, together with factor 3 expression, facilitates further local thrombin generation.

    [On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients] Publishing Authors By Initials

     ,ii dement'evaII Dement'eva,vg gladyshevaVG Gladysheva,ma charnaiaMA Charnaia,iua morozovIuA Morozov,

    For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    [On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Vestnik Rossi?sko? akademii meditsinskikh nauk / R

    VOLUME:

    Page Numbers: 21-5

    Journal Abbreviation: Vestn. Akad. Med. Nauk SSSR

    ISSN: 0869-6047

    DAY: 20

    MONTH: 12

    YEAR: 2006

    [On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients] Information

    Number of References:

    LANGUAGE: rus

    NlmUniqueID: 9215641

    [On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients] Keywords Mesh Terms:

    KEYWORDS: Treatment Outcome

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: [On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients] Information

    Substance Name: Factor VIIa

    Registry Number: EC 3.4.21.21

    Grant and Affiliation Information for [On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients]

    AFFILIATION:

    Country: Russia (Federation)

    Russia (Federation) Research PublicationRussia (Federation) Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Vestn Ross Akad Med Nauk

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    On the mechanism of action of recombinant activated factor VII in massive non-hemophylic bleeding in cardiosurgical patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News